Results 1 to 10 of about 721,020 (271)

Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents

open access: yesFrontiers in Medicine, 2021
Anemia is a common complication in chronic kidney disease (CKD), and is associated with a reduced quality of life, and an increased morbidity and mortality. The mechanisms involved in anemia associated to CKD are diverse and complex.
J. Portolés   +3 more
semanticscholar   +3 more sources

Anemia of inflammation.

open access: yesBlood, 2019
Anemia of inflammation (AI), also known as anemia of chronic disease (ACD), is regarded as the most frequent anemia in hospitalized and chronically ill patients.
G. Weiss, T. Ganz, L. Goodnough
semanticscholar   +2 more sources

Anemia epidemiology, pathophysiology, and etiology in low‐ and middle‐income countries

open access: yesAnnals of the New York Academy of Sciences, 2019
Anemia affects a third of the world's population and contributes to increased morbidity and mortality, decreased work productivity, and impaired neurological development.
C. Chaparro, P. Suchdev
semanticscholar   +1 more source

Iron Deficiency and Iron Deficiency Anemia: Implications and Impact in Pregnancy, Fetal Development, and Early Childhood Parameters

open access: yesNutrients, 2020
A normal pregnancy consumes 500–800 mg of iron from the mother. Premenopausal women have a high incidence of marginal iron stores or iron deficiency (ID), with or without anemia, particularly in the less developed world.
R. Means
semanticscholar   +1 more source

Pernicious Anemia

open access: yesDefinitions, 2020
Copyright 2009, American Society for Investigative Pathology 32 In 1855, Thomas Addison at Guy's Hospital described a lethal, idiopathic anemia that in 1872 was given the name pernicious anemia by Biemer.
R. B. Farnsworth
semanticscholar   +1 more source

Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.

open access: yesNew England Journal of Medicine, 2019
BACKGROUND Roxadustat (FG-4592) is an oral inhibitor of hypoxia-inducible factor (HIF) prolyl hydroxylase that stimulates erythropoiesis and regulates iron metabolism.
N. Chen   +20 more
semanticscholar   +1 more source

Prevalence and Predictive Value of Anemia and Dysregulated Iron Homeostasis in Patients with COVID-19 Infection

open access: yesJournal of Clinical Medicine, 2020
Infections with SARS-CoV-2 can result in severe clinical manifestations. As such patients present with systemic inflammation, we studied the prevalence and predictive value of anemia of inflammation (AI) or functional iron deficiency (FID), originating ...
R. Bellmann-Weiler   +8 more
semanticscholar   +1 more source

[Anemia of chronic disease].

open access: yesTidsskrift for Den Norske Laegeforening, 2017
Anemi ved kronisk sykdom er i Vesten den vanligste formen for anemi hos hospitaliserte pasienter over 50 år. Diagnostikken kompliseres av at de klassiske biokjemiske parametrene, brukt til vurdering av jernstatus, påvirkes av immunaktiveringen som er ...
I. M. Hardang, K. Lilleholt, T. Hagve
semanticscholar   +1 more source

Anemia among Women of Reproductive Age: An Overview of Global Burden, Trends, Determinants, and Drivers of Progress in Low- and Middle-Income Countries

open access: yesNutrients, 2021
Relatively little progress has been made in reducing anemia prevalence among women of reproductive age (WRA anemia). Interventions, policies and programs aimed at reducing WRA anemia have the potential to improve overall not only women’s, but also ...
Aatekah Owais   +3 more
semanticscholar   +1 more source

Aplastic Anemia

open access: yesDefinitions, 2020
Aplastic anemia is an historic disease. The first patient was described by the young Paul Ehrlich in 1885, “anemia aplastique” originated with Vaquez in 1904, and its clinical features were described by Cabot and other pathologists in the early 20 th ...
Tony Marchand, Michaël Loschi
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy